Citrus Pulp CAS: 94266-47-4
Related Insights
Hormuz Strait Traffic Drops to Single Digits Again
Vessel traffic through the Strait of Hormuz has fallen to single digits, a stark return to the lows seen in 2020. This sharp decline threatens chemical exports, fertilizer logistics, and global shipping schedules. Supply chains must adapt to the new reality of limited tanker movements and heightened uncertainty.
Algal Oil and Marine Bio-Based Ingredients: A Hormuz-Independent Supply Strategy for Food Ingredient Buyers
Fermentation-based marine ingredients such as algal DHA, astaxanthin and beta-glucan offer food manufacturers a more resilient supply chain during periods of global shipping disruption. Procurement teams should understand why production geography matters as much as ingredient performance.
SABIC’s Q3 Supply Calendar: Saudi Export Strategy Sets Global Chemical Prices
SABIC’s Q3 supply calendar has emerged as a key indicator for polymer and chemical flows worldwide, with Ras Tanura’s logistics network playing a pivotal role. The company’s allocation decisions influence pricing, inventory levels, and competitive dynamics across major export markets.
Top 10 Market Intelligence Data Points for July 1, 2026
July 1 begins H2 2026 with conflicting market signals for chemical procurement professionals. While oil prices remain stable and diplomacy improves, shipping disruption, insurance risk, new regulations, and supply chain bottlenecks continue shaping one of the most complex operating environments the chemical industry has faced all year.
Stranded Vessel Update: The 485 Ships That Remain and How the Exit Queue Works
Although Gulf shipping has improved significantly since the peak of the Hormuz crisis, hundreds of vessels remain awaiting transit. Understanding the commercial priority system governing departures is essential for chemical buyers tracking delayed cargoes and planning H2 2026 deliveries.
Pharmaceutical Supply Chain: H1 2026 Closing Risk Assessment
The first half of 2026 exposed major vulnerabilities in pharmaceutical supply chains. API concentration, shipping disruptions, and logistics risks are reshaping procurement strategies for H2 2026 and beyond.
Don't miss out on our updates! Subscribe to our newsletter now
We're committed to your privacy. Tradeasia uses the information you provide to us to contact you about our relevant content, products, and services. For more information, check out our privacy policy.